The store will not work correctly when cookies are disabled.
1-(Butyl)-3-((1H-benzo[d]1,2,3-triazol-1-yl)methyl)imidazolium chloride
ID: ALA3759630
PubChem CID: 127027683
Max Phase: Preclinical
Molecular Formula: C14H18ClN5
Molecular Weight: 256.33
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCn1cc[n+](Cn2nnc3ccccc32)c1.[Cl-]
Standard InChI: InChI=1S/C14H18N5.ClH/c1-2-3-8-17-9-10-18(11-17)12-19-14-7-5-4-6-13(14)15-16-19;/h4-7,9-11H,2-3,8,12H2,1H3;1H/q+1;/p-1
Standard InChI Key: MLVOKUNWVKCCRZ-UHFFFAOYSA-M
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
9.7886 3.8517 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
4.2449 4.2986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6500 2.9355 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7388 1.9224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0412 2.6666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7359 4.1352 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1812 2.6271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7411 5.2462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2817 6.6750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2886 7.7879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9212 8.9303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
2 6 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 1 0
8 12 1 0
13 14 1 0
14 15 2 0
15 16 1 0
11 16 2 0
12 13 2 0
7 8 1 0
3 7 1 0
17 18 1 0
18 19 1 0
19 20 1 0
6 17 1 0
M CHG 2 1 -1 3 1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 256.33 | Molecular Weight (Monoisotopic): 256.1557 | AlogP: 1.83 | #Rotatable Bonds: 5 |
Polar Surface Area: 39.52 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.17 | CX LogP: -0.78 | CX LogD: -0.78 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.65 | Np Likeness Score: -1.66 |
References
1. Karataş MO, Uslu H, Alıcı B, Gökçe B, Gencer N, Arslan O, Arslan NB, Özdemir N.. (2016) Functionalized imidazolium and benzimidazolium salts as paraoxonase 1 inhibitors: Synthesis, characterization and molecular docking studies., 24 (6): [PMID:26879855] [10.1016/j.bmc.2016.02.012] |